HUTCHMED (China) Ltd banner

Intrinsic Value

Is HMDCF undervalued or overvalued?

See the intrinsic value estimate for HUTCHMED (China) Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

HMDCF Intrinsic Value
LOCKED
Unlock
Today vs. history

HMDCF looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with HMDCF’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor HMDCF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price $2.16
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to HMDCF

Fundamental Analysis

What HUTCHMED (China) Does

Pharmaceuticals Health Care

HUTCHMED is a biopharmaceutical company that discovers and develops cancer medicines, especially targeted therapies and immunotherapies. It also works on treatments for immune and inflammatory diseases. The company’s main job is to take drug candidates from research into clinical testing and then turn the successful ones into approved medicines for patients.

Headquarters
Hong Kong HK
Employees
1 796
IPO date
May 19, 2006
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
HUTCHMED (China) Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one HMDCF stock?

The intrinsic value for HUTCHMED (China) Ltd (HMDCF) under the Base Case is hidden USD.

Is HMDCF stock undervalued or overvalued?

Compared with the current market price of 2.16 USD, the stock appears hidden.

Back to Top